Loading
Latest filing published 01 Apr 2025 for Perspective Therapeutics, Inc., €46k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Johan M. Spoor discloses dealings in 2 companies, chiefly Perspective Therapeutics, Inc. and GridAI Technologies Corp. Between 10 November 2017 and 28 March 2025, the trades on record add up to 10 filings.
On the market, this insider has only ever bought: 8 purchases, €333k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants. So far in 2025, the count stands at 2 purchases and no sales.
Half of the purchases are above €36k and half below. Of 8 purchases, 5 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The latest filing, published on 1 April 2025, reports an open-market purchase of €9,514 in Perspective Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations